Keywords: romania, antibiotice, hopes, growth, posted, healthy, seven-month
Romania's Antibiotice hopes for US growth
Article | 18 September 2000
Antibiotice of Romania has posted healthy seven-month 2000 profits of30.8 billion lei ($1.4 million) on turnover worth 352 billion lei, according to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
